Question 1

What are the most cited papers from Pulmonx (United States)?

Accepted Answer

The most cited paper from Pulmonx (United States) is "A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE)" (Gerard J. Criner et al., 2018), with 445 citations. Next come "Predicting Lung Volume Reduction after Endobronchial Valve Therapy Is Maximized Using a Combination of Diagnostic Tools" (108) and "Diagnostic performance comparison of the C hartis S ystem and high‐resolution computerized tomography fissure analysis for planning endoscopic lung volume reduction" (95).

Question 2

Which research topics does Pulmonx (United States) publish most on?

Accepted Answer

By volume in 2022-now: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Respiratory viral infections research, Chronic Obstructive Pulmonary Disease (COPD) Research and Respiratory Support and Mechanisms.

Question 3

Which fields of science does Pulmonx (United States) work in?

Accepted Answer

In all years, 69% of research at Pulmonx (United States) is in Health Sciences, 29% in Physical Sciences. Its largest fields are Medicine (67%), Engineering (18%), Energy (6%). It does 1.8× the world's share of Health Sciences.

Question 4

Is Pulmonx (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 178% higher than in 2018-2021.